Artivion Inc
AORT
Get informed when a big investor buys or sells
+ Follow
Current Fair Value
132.2% downsideOvervalued by 132.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.08 Billion |
|---|---|
| Enterprise Value | $1.04 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.22 |
| Beta | 1.4 |
| Outstanding Shares | 48,074,000 |
Return
| Return on Equity | 2.60% |
|---|---|
| Return on Assets | 1.32% |
| Return on Invested Capital | 4.59% |
Valuation & Multiples
| P/E Ratio | 91.25 |
|---|---|
| PEG | -23.98 |
| Price to Sales | 2.29 |
| Price to Book Ratio | 2.29 |
| Enterprise Value to Revenue | 2.26 |
| Enterprise Value to EBIT | 28.61 |
| Enterprise Value to Net Income | 88 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Next Earnings Call
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Artivion Inc
1,200 employees
CEO: James Mackin Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. Cr...
Relevant Senate Committees
This powerful committee controls taxation, trade, and entitlement spending (like Medicare). Its decisions on corporate tax policy, tariffs (affecting global supply chains and sales), and Medicare pricing directly and significantly impact Artivion's profitability and market access.
This committee allocates federal discretionary spending, directly influencing funding for healthcare programs (e.g., NIH, VA) that impact demand, research, and reimbursement for medical devices, significantly affecting Artivion's market.
This committee has direct oversight of the FDA, which is the primary regulatory body for medical device approval, manufacturing standards, and market access in the U.S. This is central to Artivion's business.
This committee's oversight of antitrust laws and intellectual property is critical for Artivion, a company reliant on patents and operating in a competitive industry. It directly influences M&A and market structure.
This committee oversees the Department of Veterans Affairs, a significant purchaser of healthcare products. Its funding decisions directly impact government healthcare contractors and demand for medical devices used by veterans.